Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the Boston Area Community Health (BACH) survey

Susan A. Hall, Teresa M. Curto, Ahunna Onyenwenyi, Gary E. Lemack, Sharon L. Tennstedt, Carol L. Link, John B. McKinlay

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Aims To compare the descriptive epidemiology of overactive bladder (OAB) of presumed neurologic origin (NOAB) to OAB of non-neurologic origin (N-NOAB). Methods Five thousand five hundred three community-dwelling persons aged 30-79 were interviewed regarding urologic symptoms (2002-2005). NOAB was defined as symptoms of urgency and/or urgency incontinence among those with a self-reported history of healthcare provider diagnosed stroke (N = 98), multiple sclerosis (N = 21), or Parkinson's disease (N = 7). N-NOAB was defined identically but occurring among those not reporting neurologic disease (ND). Prevalence estimates were weighted to reflect sampling design; chi-square, Fisher's exact, or t-tests were used to test differences. Urologic symptom interference was assessed using the Epstein scale, while the impact of urinary incontinence (UI) on health-related quality-of-life (HRQOL) was measured using a modification of the Incontinence Impact Questionnaire-7. Results Forty-five (31.0%) of 125 persons with ND and 994 (16.7%) of 5378 persons without ND reported OAB symptoms. The overall prevalence of NOAB and N-NOAB was 0.6% and 16.4%, respectively. Persons with NOAB had higher (worse) mean American Urologic Association Symptom Index scores (13.0 vs. 10.0, P = 0.09) compared to those with N-NOAB, and were significantly more likely to have diabetes, high blood pressure, cardiac disease, and fair/poor self-reported health (all P < 0.05). Mean symptom interference and UI HRQOL scores were significantly higher (worse) in the NOAB group compared to persons with N-NOAB (all P < 0.05). Conclusions Persons with NOAB appeared to have a greater burden of urologic illness with respect to symptom interference and HRQOL compared to persons with N-NOAB. Neurourol. Urodynam. 31:1149-1155, 2012. © 2012 Wiley Periodicals, Inc.

Original languageEnglish (US)
Pages (from-to)1149-1155
Number of pages7
JournalNeurourology and Urodynamics
Volume31
Issue number7
DOIs
StatePublished - Sep 2012

Fingerprint

Overactive Urinary Bladder
Health Surveys
Nervous System
Nervous System Diseases
Quality of Life
Urinary Incontinence
Independent Living
Cost of Illness
Surveys and Questionnaires
Health Personnel
Multiple Sclerosis
Parkinson Disease
Heart Diseases
Epidemiology
Stroke
Hypertension
Health

Keywords

  • epidemiology
  • neurogenic bladder
  • overactive bladder

ASJC Scopus subject areas

  • Clinical Neurology
  • Urology

Cite this

Characteristics of persons with overactive bladder of presumed neurologic origin : Results from the Boston Area Community Health (BACH) survey. / Hall, Susan A.; Curto, Teresa M.; Onyenwenyi, Ahunna; Lemack, Gary E.; Tennstedt, Sharon L.; Link, Carol L.; McKinlay, John B.

In: Neurourology and Urodynamics, Vol. 31, No. 7, 09.2012, p. 1149-1155.

Research output: Contribution to journalArticle

Hall, Susan A. ; Curto, Teresa M. ; Onyenwenyi, Ahunna ; Lemack, Gary E. ; Tennstedt, Sharon L. ; Link, Carol L. ; McKinlay, John B. / Characteristics of persons with overactive bladder of presumed neurologic origin : Results from the Boston Area Community Health (BACH) survey. In: Neurourology and Urodynamics. 2012 ; Vol. 31, No. 7. pp. 1149-1155.
@article{4159446f22014cd485025306c6b9ad29,
title = "Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the Boston Area Community Health (BACH) survey",
abstract = "Aims To compare the descriptive epidemiology of overactive bladder (OAB) of presumed neurologic origin (NOAB) to OAB of non-neurologic origin (N-NOAB). Methods Five thousand five hundred three community-dwelling persons aged 30-79 were interviewed regarding urologic symptoms (2002-2005). NOAB was defined as symptoms of urgency and/or urgency incontinence among those with a self-reported history of healthcare provider diagnosed stroke (N = 98), multiple sclerosis (N = 21), or Parkinson's disease (N = 7). N-NOAB was defined identically but occurring among those not reporting neurologic disease (ND). Prevalence estimates were weighted to reflect sampling design; chi-square, Fisher's exact, or t-tests were used to test differences. Urologic symptom interference was assessed using the Epstein scale, while the impact of urinary incontinence (UI) on health-related quality-of-life (HRQOL) was measured using a modification of the Incontinence Impact Questionnaire-7. Results Forty-five (31.0{\%}) of 125 persons with ND and 994 (16.7{\%}) of 5378 persons without ND reported OAB symptoms. The overall prevalence of NOAB and N-NOAB was 0.6{\%} and 16.4{\%}, respectively. Persons with NOAB had higher (worse) mean American Urologic Association Symptom Index scores (13.0 vs. 10.0, P = 0.09) compared to those with N-NOAB, and were significantly more likely to have diabetes, high blood pressure, cardiac disease, and fair/poor self-reported health (all P < 0.05). Mean symptom interference and UI HRQOL scores were significantly higher (worse) in the NOAB group compared to persons with N-NOAB (all P < 0.05). Conclusions Persons with NOAB appeared to have a greater burden of urologic illness with respect to symptom interference and HRQOL compared to persons with N-NOAB. Neurourol. Urodynam. 31:1149-1155, 2012. {\circledC} 2012 Wiley Periodicals, Inc.",
keywords = "epidemiology, neurogenic bladder, overactive bladder",
author = "Hall, {Susan A.} and Curto, {Teresa M.} and Ahunna Onyenwenyi and Lemack, {Gary E.} and Tennstedt, {Sharon L.} and Link, {Carol L.} and McKinlay, {John B.}",
year = "2012",
month = "9",
doi = "10.1002/nau.22232",
language = "English (US)",
volume = "31",
pages = "1149--1155",
journal = "Neurourology and Urodynamics",
issn = "0733-2467",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Characteristics of persons with overactive bladder of presumed neurologic origin

T2 - Results from the Boston Area Community Health (BACH) survey

AU - Hall, Susan A.

AU - Curto, Teresa M.

AU - Onyenwenyi, Ahunna

AU - Lemack, Gary E.

AU - Tennstedt, Sharon L.

AU - Link, Carol L.

AU - McKinlay, John B.

PY - 2012/9

Y1 - 2012/9

N2 - Aims To compare the descriptive epidemiology of overactive bladder (OAB) of presumed neurologic origin (NOAB) to OAB of non-neurologic origin (N-NOAB). Methods Five thousand five hundred three community-dwelling persons aged 30-79 were interviewed regarding urologic symptoms (2002-2005). NOAB was defined as symptoms of urgency and/or urgency incontinence among those with a self-reported history of healthcare provider diagnosed stroke (N = 98), multiple sclerosis (N = 21), or Parkinson's disease (N = 7). N-NOAB was defined identically but occurring among those not reporting neurologic disease (ND). Prevalence estimates were weighted to reflect sampling design; chi-square, Fisher's exact, or t-tests were used to test differences. Urologic symptom interference was assessed using the Epstein scale, while the impact of urinary incontinence (UI) on health-related quality-of-life (HRQOL) was measured using a modification of the Incontinence Impact Questionnaire-7. Results Forty-five (31.0%) of 125 persons with ND and 994 (16.7%) of 5378 persons without ND reported OAB symptoms. The overall prevalence of NOAB and N-NOAB was 0.6% and 16.4%, respectively. Persons with NOAB had higher (worse) mean American Urologic Association Symptom Index scores (13.0 vs. 10.0, P = 0.09) compared to those with N-NOAB, and were significantly more likely to have diabetes, high blood pressure, cardiac disease, and fair/poor self-reported health (all P < 0.05). Mean symptom interference and UI HRQOL scores were significantly higher (worse) in the NOAB group compared to persons with N-NOAB (all P < 0.05). Conclusions Persons with NOAB appeared to have a greater burden of urologic illness with respect to symptom interference and HRQOL compared to persons with N-NOAB. Neurourol. Urodynam. 31:1149-1155, 2012. © 2012 Wiley Periodicals, Inc.

AB - Aims To compare the descriptive epidemiology of overactive bladder (OAB) of presumed neurologic origin (NOAB) to OAB of non-neurologic origin (N-NOAB). Methods Five thousand five hundred three community-dwelling persons aged 30-79 were interviewed regarding urologic symptoms (2002-2005). NOAB was defined as symptoms of urgency and/or urgency incontinence among those with a self-reported history of healthcare provider diagnosed stroke (N = 98), multiple sclerosis (N = 21), or Parkinson's disease (N = 7). N-NOAB was defined identically but occurring among those not reporting neurologic disease (ND). Prevalence estimates were weighted to reflect sampling design; chi-square, Fisher's exact, or t-tests were used to test differences. Urologic symptom interference was assessed using the Epstein scale, while the impact of urinary incontinence (UI) on health-related quality-of-life (HRQOL) was measured using a modification of the Incontinence Impact Questionnaire-7. Results Forty-five (31.0%) of 125 persons with ND and 994 (16.7%) of 5378 persons without ND reported OAB symptoms. The overall prevalence of NOAB and N-NOAB was 0.6% and 16.4%, respectively. Persons with NOAB had higher (worse) mean American Urologic Association Symptom Index scores (13.0 vs. 10.0, P = 0.09) compared to those with N-NOAB, and were significantly more likely to have diabetes, high blood pressure, cardiac disease, and fair/poor self-reported health (all P < 0.05). Mean symptom interference and UI HRQOL scores were significantly higher (worse) in the NOAB group compared to persons with N-NOAB (all P < 0.05). Conclusions Persons with NOAB appeared to have a greater burden of urologic illness with respect to symptom interference and HRQOL compared to persons with N-NOAB. Neurourol. Urodynam. 31:1149-1155, 2012. © 2012 Wiley Periodicals, Inc.

KW - epidemiology

KW - neurogenic bladder

KW - overactive bladder

UR - http://www.scopus.com/inward/record.url?scp=84865228094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865228094&partnerID=8YFLogxK

U2 - 10.1002/nau.22232

DO - 10.1002/nau.22232

M3 - Article

C2 - 22674347

AN - SCOPUS:84865228094

VL - 31

SP - 1149

EP - 1155

JO - Neurourology and Urodynamics

JF - Neurourology and Urodynamics

SN - 0733-2467

IS - 7

ER -